Explore the full directors' dealings record of 바이오에프디엔씨, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Market capitalisation: €134.8bn. The latest transaction was filed on 8 April 2026 — Other. Among the most active insiders: 모상현. All data is accessible without an account.